Exelon Corp
NASDAQ:EXC
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
32.5999
40.97
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Exelon Corp
Wall Street
Price Targets
EXC Price Targets Summary
Exelon Corp
According to Wall Street analysts, the average 1-year price target for
EXC
is 44.01 USD
with a low forecast of 39.39 USD and a high forecast of 49.35 USD.
EXC Last Price Targets
Exelon Corp
The latest public price target was made on Sep 19, 2024 by
Julien Dumoulin-Smith
from
Jefferies
,
who expects
EXC
stock to
rise by 24%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Julien Dumoulin-Smith
Jefferies
|
46
USD
Upside 24% |
3 months ago
Sep 19, 2024
|
Exelon initiated with a Buy at Jefferies
TheFly
|
James Thalacker
BMO Capital
|
42
USD
Upside 13% |
7 months ago
May 3, 2024
|
Exelon (EXC) PT Raised to $42 at BMO Capital
StreetInsider
|
Steve Fleishman
Wolfe Research
|
40
USD
Upside 8% |
8 months ago
Apr 1, 2024
|
Exelon (EXC) PT Raised to $40 at Wolfe Research
StreetInsider
|
Jacob Kilstein
Argus Research
|
45
USD
Upside 22% |
9 months ago
Mar 20, 2024
|
Argus Defends Exelon (EXC): 'Recent selloff creates opportunity as rate changes drive growth'
StreetInsider
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is EXC's stock price target?
Price Target
44.01
USD
According to Wall Street analysts, the average 1-year price target for
EXC
is 44.01 USD
with a low forecast of 39.39 USD and a high forecast of 49.35 USD.
What is Exelon Corp's Revenue forecast?
Projected CAGR
3%
For the last 8 years the
compound annual growth rate for
Exelon Corp's revenue is
-4%.
The projected
CAGR
for the next 4 years is
3%.
What is Exelon Corp's Operating Income forecast?
Projected CAGR
10%
For the last 8 years the
compound annual growth rate for
Exelon Corp's operating income is
-1%.
The projected
CAGR
for the next 4 years is
10%.
What is Exelon Corp's Net Income forecast?
Projected CAGR
7%
For the last 8 years the
compound annual growth rate for
Exelon Corp's net income is
0%.
The projected
CAGR
for the next 4 years is
7%.
You don't have any saved screeners yet
